HERCESSI (trastuzumab-strf)

About Accord Biopharma

Accord BioPharma is a private, commercial-stage biopharmaceutical company specializing in biosimilars and generic specialty products, primarily in oncology and immunology. The company has successfully gained FDA approvals for key biosimilars like FILKRI (filgrastim) and HERCESSI (trastuzumab) and has secured formulary placements with major pharmacy benefit managers. Its strategy centers on enhancing patient access through affordable therapies and comprehensive support services, positioning it as a growing player in the competitive biosimilars market.

Therapeutic Areas